Literature DB >> 15229911

Maxillary length at 11-14 weeks of gestation in fetuses with trisomy 21.

S Cicero1, P Curcio, G Rembouskos, J Sonek, K H Nicolaides.   

Abstract

OBJECTIVE: To determine the value of measuring maxillary length at 11-14 weeks of gestation in screening for trisomy 21.
METHODS: In 970 fetuses ultrasound examination was carried out for measurement of crown-rump length (CRL), nuchal translucency and maxillary length, and to determine if the nasal bone was present or absent, immediately before chorionic villus sampling for karyotyping at 11-14 weeks of gestation. In 60 cases the maxillary length was measured twice by the same operator to calculate the intraobserver variation in measurements.
RESULTS: The median gestation was 12 (range, 11-14) weeks. The maxilla was successfully examined in all cases. The mean difference between paired measurements of maxillary length was -0.012 mm and the 95% limits of agreement were -0.42 (95% CI, -0.47 to -0.37) to 0.40 (95% CI, 0.35 to 0.44) mm. The fetal karyotype was normal in 839 pregnancies and abnormal in 131, including 88 cases of trisomy 21. In the chromosomally normal group the maxillary length increased significantly with CRL from a mean of 4.8 mm at a CRL of 45 mm to 8.3 mm at a CRL of 84 mm. In the trisomy 21 fetuses the maxillary length was significantly shorter than normal by 0.7 mm and in the trisomy 21 fetuses with absent nasal bone the maxilla was shorter than in those with present nasal bone by 0.5 mm. In fetuses with other chromosomal defects there were no significant differences from normal in the maxillary length.
CONCLUSION: At 11-14 weeks of gestation, maxillary length in trisomy 21 fetuses is significantly shorter than in normal fetuses. Copyright 2004 ISUOG. Published by John Wiley & Sons, Ltd.

Mesh:

Year:  2004        PMID: 15229911     DOI: 10.1002/uog.1077

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

2.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

3.  Assessment of Midfacial Hypoplasia in Down Syndrome Fetuses - Validity of a Two-Line Approach and Introduction of a Novel Angle (Maxilla-Mandible-Nasion Angle).

Authors:  J Weichert; M Gembicki; J Ribbat-Idel; D R Hartge
Journal:  Ultrasound Int Open       Date:  2016-05

Review 4.  Imaging findings in Down syndrome.

Authors:  Rupa Radhakrishnan; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2014-04-16

5.  Growth of the hard palate in infants with Down syndrome compared with healthy infants-A retrospective case control study.

Authors:  Daniel Klingel; Ariane Hohoff; Robert Kwiecien; Dirk Wiechmann; Thomas Stamm
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.